NASDAQ: IMNMImmunome Inc Stock Ownership - Who owns Immunome?
Insider buying vs selling
Have Immunome Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Rapp | Director | 2023-10-02 | 253,806 | $5.91 | $1.50MBuy |
| Clay B. Siegall | President and CEO | 2023-10-02 | 169,204 | $5.91 | $1,000.00kBuy |
| Bruce Turner | Chief Strategy Officer | 2023-10-02 | 42,300 | $5.91 | $249.99kBuy |
IMNM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IMNM insiders and whales buy or sell their stock.
IMNM Shareholders
What type of owners hold Immunome Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 6.54% | 3,906,143 | $58.47M | Institution |
| Redmile Group LLC | 6.50% | 3,879,415 | $58.07M | Institution |
| Ecor1 Capital LLC | 6.50% | 3,879,415 | $58.07M | Institution |
| Isaac Barchas | 4.75% | 2,834,008 | $42.43M | Insider |
| Vanguard Group Inc | 2.91% | 1,740,026 | $26.05M | Institution |
| Janus Henderson Group PLC | 2.33% | 1,391,471 | $20.83M | Institution |
| Avidity Partners Management LP | 2.23% | 1,333,479 | $19.96M | Institution |
| Michael Rapp | 2.14% | 1,279,914 | $19.16M | Insider |
| Price T Rowe Associates Inc | 1.76% | 1,051,222 | $15.74M | Institution |
| Woodline Partners LP | 1.55% | 922,892 | $13.82M | Institution |
IMNM vs Biotech Stocks
Immunome Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.